Fred Poordad.

Fred Poordad, M .D., Christophe Hezode, M.D., Roger Trinh, M.D., M.P.H., Kris V. Kowdley, M.D., Stefan Zeuzem, M.D., Kosh Agarwal, M.D., Mitchell L. Shiffman, M.D., Heiner Wedemeyer, M.D., Thomas Berg, M.D., Eric M. Yoshida, M.D., Xavier Forns, M.D., Sandra S. Lovell, Ph.D., Barbara Da Silva-Tillmann, M.D., Christine A. Collins, Ph.D., Andrew L. Campbell, M.D., Thomas Podsadecki, M.D., and Barry Bernstein, M.D.2,3 Approximately 25 percent of persons with HCV illness in the United States have cirrhosis, and this number is likely to rise to 37 percent by 2020.4,5 Eradication of HCV with antiviral therapy decreases the chance of hepatic decompensation, hepatocellular carcinoma, and death from a liver-related cause or any cause.11-19 In addition, treatment for HCV infection, especially with interferon-containing regimens, in individuals with cirrhosis is associated with increased toxic effects.20 Interferon-free combinations of direct-acting antiviral agents are therefore needed to improve the efficacy and safety of HCV treatment in sufferers with cirrhosis.

QuantorMed+ and QuantorVet+ Imaging Software, combined with the FireCR+M Veterinary and Medical Readers, will be available worldwide in the 1st quarter of 2013.. 3Disk to introduce QuantorMed+ Imaging Software at RSNA annual meeting 3DISC, a manufacturer of digital imaging solutions, will introduce its next-generation QuantorMed+ and QuantorVet+ Imaging Software at the 2012 Radiological Society of THE UNITED STATES conference in Chicago Nov. 25-30 . Quantor+ Imaging Software provides services using 3DISC's family of FireCR+ Veterinary and Medical Readers with optimized picture acquisition, processing, and administration capabilities. With QuantorMed+ and QuantorVet+ Imaging Software, picture acquisition is supported by a thorough set of anatomies and exams.